Name | TPN171 |
---|
Description | TPN171 is a potent, selective and oral bioavailable inhibitor of phosphodiesterase type 5 (PDE5) with an IC50 of 0.62 nM, being developed for the treatment of pulmonary arterial hypertension (PAH)[1]. |
---|---|
Related Catalog | |
Target |
PDE5:0.62 nM (IC50) |
References |
Molecular Formula | C24H35N5O3 |
---|---|
Molecular Weight | 441.57 |